B-Clamp: Laparoscopic Clip-Gastroplasty With The Use Of Bariclip

Sponsor
University of Rome Tor Vergata (Other)
Overall Status
Completed
CT.gov ID
NCT05557084
Collaborator
(none)
50
2
9
25
2.8

Study Details

Study Description

Brief Summary

Sleeve gastrectomy, the most commonly performed bariatric surgery procedure, carries limitations both short-term including postoperative complications such as hemorrhage and gastric fistula and long-term such as weight regain and gastro-esophageal reflux. A new procedure has been proposed to overcome many of these limitations: laparoscopic vertical clip gastroplasty (LVCG) with Bariclip. Primary outcome were major postoperative complications. Secondary outcomes included weight loss, incidence of de-novo GERD and comorbidity resolution.

Condition or Disease Intervention/Treatment Phase
  • Procedure: laparoscopic vertical clip gastroplasty (LVCG) with Bariclip.

Detailed Description

Methods. The investigators performed a review of data from a prospectively collected database. All patients submitted to primary LVCG were examined. Patients were submitted to LVCG Between July 2021 and March 2022. Collected data included demographic factors, pre-operative weight, pre-operative BMI, operative time, surgical complications, and clinical outcomes in terms of short and mid-term weight loss.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Laparoscopic Clip-Gastroplasty With The Use Of Bariclip
Actual Study Start Date :
Jul 1, 2021
Actual Primary Completion Date :
Mar 31, 2022
Actual Study Completion Date :
Mar 31, 2022

Outcome Measures

Primary Outcome Measures

  1. % Excess Weight Loss [1 year]

    Weight loss after laparoscopic vertical clip gastroplasty during the follow-up

Secondary Outcome Measures

  1. Post-operative complications [1 year]

    Complications occurred after laparoscopic vertical clip gastroplasty during the follow-up

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

BMI > 40 BMI > 35 and comorbidities BMI > 30 with poorly controlled Diabetes mellitus II or hypertension

Exclusion Criteria:

Alcoholism Drug addiction Psychiatric Disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Michela Campanelli Rome RM Italy 00133
2 Department of Bariatric and Metabolic Surgery, San Carlo of Nancy Hospital and University of Rome "Tor Vergata", Rome, Italy Roma Italy 00133

Sponsors and Collaborators

  • University of Rome Tor Vergata

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Paolo Gentileschi, Head of Department of Bariatric and Metabolic Surgery, University of Rome Tor Vergata
ClinicalTrials.gov Identifier:
NCT05557084
Other Study ID Numbers:
  • UNRome1
First Posted:
Sep 27, 2022
Last Update Posted:
Sep 27, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Paolo Gentileschi, Head of Department of Bariatric and Metabolic Surgery, University of Rome Tor Vergata
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 27, 2022